Kezar Life Sciences, Inc.KZR

Market cap

$45.73M

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	24	15	21	63	40	35	42
Marketable securities, current	83	63	119	145	236	166	90
Total cash & short-term investments	107	78	140	208	277	201	132
Total current assets	110	81	145	212	286	207	137
Property, plant and equipment, net	5	4	3	3	3	4	3
Total non-current assets	5	8	7	6	14	14	7
Total assets	115	90	152	218	300	221	145
Accounts payable	0	1	2	2	2	8	4
Total current liabilities	3	6	6	8	11	18	20
Long-term debt, non-current	-	-	-	10	10	10	5
Total non-current liabilities	3	5	4	13	19	16	7
Total liabilities	6	11	11	21	30	34	28
Common stock and paid-in capital	0	0	0	0	0	0	0
Retained earnings	-49	-84	-126	-181	-249	-351	-434
Stockholders' equity	109	78	141	197	270	188	117
Total debt	-	-	-	10	10	10	5
Net debt	-	-	-	-199	-267	-191	-127
D/E ratio (%)	-	-	-	4.9	3.6	5.4	4.4